Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

J Res Educ Indian Med . 2007; 13(1): 47-55


A CLINICAL STUDY ON SPERMATOGENIC EFFECT OF Kshiravidari ( Ipomea digitata Linn ) IN OLIGOZOOSPERMIA

GIRISH K J, ANUP B THAKAR, M S BAGHEL.

Abstract
In the present clinical study, total 65 patients of oligozoospermia (< 40
mil/ml three successive weekly semen analyses) were managed in two groups viz.
study (Kshiravidari) group (n=35) and placebo group (n=30). In Kshiravidari group,
Kshiravidari (Ipomea digitata Linn.) tuber was administered in the tablet form (each 500
mg) in a dose of 6 gm per day in divided doses, and in placebo group, Bhrista Godhuma
Churna (fried wheat powder) in capsule form [4 capsules / day (each 500 mg)] was
administered, in both therapy with milk as Anupana. In both the groups, therapy was
given for one and half month (45 days), further 45 days of follow-up. Semen examination
was carried out after completion of therapy i.e. on 45th day. During follow up period
semen examination was done 15 days after completion of therapy i.e. on 60th day, and
second examination was done 45 days after completion of treatment i.e. on 90th day.
Clinical study has shown that Kshiravidari (Ipomea digitata Linn.) increases the sperm
count (mil/ml) (mild to moderate degree) and also total sperm count (mil) in patients of
oligozoospermia. This proves Vrishya property of Kshiravidari as potent spermatogenic
agent. However, due to the increase in the viscosity and liquefaction time, the drug
decreases the RLP (Rapid Linear Progressive) and SLP (Slow Linear Progressive) motility
(%), and simultaneously increases the NP (Non-Progressive) and IMM (Immotile) motility
(%) of sperm. Three patients of oligozoospermia were able to impregnate their partners
within total of 60 days of duration of follow-up period, which also shows the fertility
enhancing effect of Kshiravidari.

Key words: Male infertility, Oligozoospermia, Kshiravidari, Ipomea digitata Linn.



Share this Article


Advertisement
American Journal of Preventive Medicine and Public Health

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.